Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo

Pharmacology and Toxicology

Volumn 79, Issue 3, 1996, Pages 124-130

  Ding, Xi Qin ^a   Håkanson, Rolf ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 1 [5 (3 AZABICYCLO[3.2.2]NON 3 YL) 2,3 DIHYDRO 1 METHYL 2 OXO 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; GASTRIN RECEPTOR; HISTIDINE DECARBOXYLASE; N (4 BROMOPHENYL) 3 OXO 4,5 DIPHENYL 1 PYRAZOLIDINECARBOXAMIDE; RP 73870; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STOMACH EMPTYING;

ANIMALIA;

EID: 0029957166     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00255.x     Document Type: Article

References (39)

1. Asahara, M., Y. Kinoshita, H. Nakata, Y. Matsushima, Y. Naribayashi, A. Nakamura, H. Matsui, K. Chihara, J. Yamamoto, A. Ichikawa & T. Chiba: Gastrin receptor genes are expressed in gastric parietal and ECL cells of Mastomys natalensis. Dig. Dis. Sci. 1994, 39, 2149-2156.
2. Beinfeld, M. C.: Cholecystokinin in the central nervous system: A minirevievv. Neuropeptides 1983, 3, 411-427.
3. Bertrand, P., G. A. Bohme, C. Durieux, C. Guyon, M. Capet, B. Jeantaud, P. Boudeau, B. Ducos, C. E. Pendley & G. E. Martin: Pharmacological properties of ureido-acetamides, new potent and selective non-peptide cholecystokinin/gastrin receptor antagonist. Eur. J. Pharmacol. 1994, 262, 233-245.
4. 3H] L-365,260: A new potent and selective brain cholecystokinin (cholecystokinin-B) and gastrin receptor antagonist radioligand. Mol. Pharmacol. 1989, 35, 803-810.
5. Chen, D. H.-J. Monstein, A.-G. Nylander, C-M. Zhao, F. Sundler & R. Håkanson: Acute responses of rat stomach enterochromaffinlike cells to gastrin: Secretory activation and adaptation. Gastroenterology 1994, 107, 18-27.
6. Chiba, T., Y. Kinoshita, T. Morishita, H. Nakata, A. Nakamura & S. Hosoda: Receptors for gastrin on gastric carcinoid tumor membranes of Mastromys natalensis. Biochem. Biophys. Res. Communs. 1991, 177, 739-744.
7. Ding, X.-Q., D. Chen, E. Rosengren, L. Persson & R. Håkanson: Comparison between activation of ornithine decarboxylase and histidine decarboxylase in rat stomach. Amer. J. Physiol. 1996, 270 (Gastrointest. Liver Physiol. 33), G476-G486.
8. Ding, X.-Q., D. Chen & R. Håkanson: Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase. Gastroenterology 1995, 109, 1181-1187.
9. Green, T., R. Dimaline, S. Peikin & G. J. Dockray: Action of the cholecystokinin antagonist L-364,718 on gastric emptying in the rat. Amer. J. Physiol. (Gastrointest. Liver Physiol. 18) 1988, 255, G685-689.
10. Håkanson, R., H. Blom, E. Carlsson, H. Larsson, B. Ryberg & F. Sundler: Hypergastrinemia produces trophic effects in stomach but not in pancreas and intestine. Regul. Pept. 1986, 13, 225-233.
11. Håkanson, R., D. Chen & F. Sundler: The ECL cells. In: Physiology of the gastrointestinal tract. Vol. 2. Ed.: L. R. Johnson. Raven Press, New York 1994, pp. 1171-1184.
12. Håkanson, R., Y. Tielemans, D. Chen, K. Andersson, B. Ryberg, H. Mattsson & F. Sundler: The biology and pathobiology of the ECL cells. Yale J. Biol. Med. 1992, 65, 761-774.
13. Hill, D. R., N. J. Campbell, T. M. Shaw & G. N. Woodruff: Autoradiographic localization and biochemical characterization of peripheral type cholecystokinin receptors in rat CNS using highly selective non-peptide cholecystokinin antagonists. J. Neurosci. 1987a, 7, 2967-2976.
14. Hill, D. R., T. M. Shaw & G. N. Woodruff: Species differences in the localization of "peripheral" type cholecystokinin receptors in rodent brain. Neurosci. Lett. 1987b, 79, 286-298.
15. Innis, R. B & S. H. Snyder: Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. USA 1980, 77, 6917-6928.
16. Kawabata, S., S. Kanayama, Y. Shinomura, Y. Miyazaki, I. Imamura, K. Moriwaki, H. Wada & S. Tarui: Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260 on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat. Regul. Pept. 1991, 35, 1-10.
17. Kopin, A. S., Y.-M. Lee, L. J. McBride, E. W. Miller, M. Lu, H. Y. Lin, L. F. Kolakowski & M. Beinborn: Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. USA 1992, 89, 3605-3609.
18. Larsson, H., E. Carlsson, H. Mattsson, L. Lundell, F. Sundler, G. Sundell, B. Wallmark, T. Watanabe & R. Hàkanson: Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Study with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986, 90, 391-399.
19. Lee, M., M. Beinborn, E. M. McBride, M. Lu, L. F. Jr. Kolaowski & A. S. Kopin: The human brain cholecystokinin-B gastrin receptor. J. Biol. Chem. 1993, 268, 8164-8169.
20. Lotti, V. J., D. J. Cerino, P. J. Kling & R. S. L. Chang: A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: Comparative potencies and durations of action of nonpeptide antagonists. Life Sci. 1987a, 39, 1631-1638.
21. Lotti, V. J., R. G. Pendleton, G. J. Gould, H. M. Hanson, R. S. C. Chang & B. V. Clineschmidt: In vivo pharmacology of L-364,718. a new potent nonpeptide peripheral cholecystokinin antagonist. J. Pharmacol. Exp. Therap. 1987b, 241, 103-109.
22. Lotti, V. J. & R. S. L. Chang: A new potent and selective nonpeptide gastrin antagonist and brain cholecystokinin receptor (cholecystokinin-B) ligand: L-365,260. Eur. J. Pharmacol. 1989, 162, 273-280.
23. Nishida, A., Y. Takinami, H. Yuki, A. Kobayashi, S. Akuzawa, T. Kamato, H. Ito, M. Yamano, Y. Ngakura & K. Miyata: YM022{(R)-1-[2,3-dihydro-1-(2′-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepine-3-yl]-3-(3-methylphenyl)urea}, apotent and selective gastrin cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. J. Pharmacol. Exp. Therap. 1994a, 270, 1256-1262.
24. Nishida, A., K. Miyata, R. Tsutsumi, H. Yuki, S. Akuzawa, A. Kobayashi, T. Kamato, H. Ito, M. Yamano, Y. Katuyama, M. Satoh, M. Ohta & K. Honda: Pharmacological profile of (R)-1-[2,3-Dihydro-1-(2′-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepine-3-yl] 3(3methylphenyl)urea(YM022), a new potent and selective gastrin cholecystokinin-B receptor antagonist, inH vivo and in vitro. J. Pharmacol. Exp. Therap. 1994b, 269, 725-731.
25. Patel, S., A. J. Smith, K. L. Chapman, A. E. Fletcher, J. A. Kemp, G. R. Marshall, R. J. Hargreaves, W. Ryecroft & S. D. Iversen: Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo. Mol. Pharmacol. 1994, 46, 943-948.
26. Pendley, C. E., L. R. Fitzpatrick, A. J. Capolino, M. A. Davis, N. J. Esterline, A. Jakubowska, P. Bertrand, C. Guyon, M.-C. Dubroeucq & G. E. Martin: RP73870, a gastrin cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat. J. Pharmacol. Exp. Therap. 1995, 273, 1015-1022.
27. Pisegna, J. R., A. D. Weerth, K. Huppi & S. A. Wank: Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosmal localization. Biochem. Biophys. Res. Commun. 1992, 189, 296-303.
28. Prinz, C., M. Kajimura, D. R. Scott, F. Mercier, H. F. Helander & G. Sachs: Histamine secretion from rat enterochromaffinlike cells. Gastroenterology 1993, 105, 449-461.
29. Prinz, C., D. R. Scott, D. Hurwitz, H. F. Helander & G. Sachs: Gastrin effects on isolated rat enterochromaffine-like cells in primary culture. Amer. J. Physiol. (Gastrointest. Liver Physiol. 30) 1994, 267, G663-675.
30. Rasmussen, K., D. R. Helton, J. E. Berger & E. Scearce: The cholecystokinin-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. NeuroReport 1993, 5, 154-156.
31. Roche, S., T. Gusdinar, J.-P. Bali & R. Magous: "Gastrin" and "cholecystokinin" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa. I. Characterization by means of agonists. Biochem. Pharmacol. 1991a, 42, 765-770.
32. Roche, S., T. Gusdinar, J.-P. Bali & R. Magous: "Gastrin" and "cholecystokinin" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa. II. Characterization by means of selective antagonists L-364,718 and L-365,260. Biochem. Pharmacol. 1991b, 42, 771-776.
33. 2+ mobilization. Eur. J. Pharmacol. 1994, 269, 249-254.
34. Sandvik, A. K. & H. L. Waldum: Cholecystokinin-B (gastrin) receptor regulates gastric histamine release and acid secretion. Amer. J. Physiol. (Gastrointest. Liver Physiol. 25) 1991, 260, G925-928.
35. Showell, G. A., S. Bourrain, J. G. Neduvelil, S. R. Fletcher, R. Baker, A. P. Watt, A. E. Fletcher, S. B. Freedman, J. A. Kemp, G. R. Marshall, S. Patel, A. J. Smith & V. G. Matassa: High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine cholecystokinin-B/gastrin receptor antagonists containing a cationic solubilizing group. J. Medicin. Chem. 1994, 37, 719-721.
36. Silvente-Poirot, S., M. Dufresne, N. Vaysse & D. Fourmy: The peripheral cholecystokinin receptors. Eur. J. Biochem. 1993, 215, 513-529.
37. Walsh, J. H.: Gastrointestinal hormones. In: Physiology of the gastrointestinal tract. Ed.: L. R. Johnson. Raven Press, New York, 1994, pp. 2-30.
38. Wank, S. A., R. Harkins, R. T. Jensen, H. Shapira, A. D. Weerth & T. Slattery: Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Natl. Acad. Sci. USA 1992a, 89, 3125-3129.
39. Wank, S. A., J. R. Pisegna & A. D. Weerth: Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc. Natl. Acad. Sci. USA 1992b, 89, 8691-8695.